Clinical Trials in New York

Showing 21781-21800 of 22,668 trials

Study of the 2.25mm Sirolimus-Eluting Stent in the Treatment of Patients With Coronary Artery Lesions

NCT00232739

The main objective of this study is to assess the safety and effectiveness of the sirolimus-eluting Bx VELOCITYTM stent in reducing in-lesion restenosis in patients with de novo native coronary artery lesions.

Coronary Artery Disease

Cordis US Corp.100 participantsStarted Sep 2003

New York, New York, United States

COMPLETEDPhase 3< 1 mile

Multicenter Study of Rasagiline in Parkinson's Disease Patients Using Levodopa and Experiencing Motor Fluctuations

NCT00203034

Study for patients currently using Levodopa/Carbidopa who will be assigned to receive either Rasagiline or Placebo

Parkinson's Disease

Teva Branded Pharmaceutical Products R&D, Inc.472 participantsStarted May 2000

Chicago, Illinois, United States • New York, New York, United States • Rochester, New York, United States +1 more locations

COMPLETEDPhase 3< 1 mile

ARIES - Ambrisentan in Patients With Moderate to Severe Pulmonary Arterial Hypertension (PAH)

NCT00091598

The primary objective is to determine the effect of ambrisentan on exercise capacity in subjects with PAH.

Pulmonary Hypertension

Gilead Sciences372 participantsStarted Jan 2004

Phoenix, Arizona, United States • Phoenix, Arizona, United States • Los Angeles, California, United States +43 more locations

Study of the 2.25mm Sirolimus-Eluting Stent in the Treatment of Patients With Coronary Artery Lesions

Multicenter Study of Rasagiline in Parkinson's Disease Patients Using Levodopa and Experiencing Motor Fluctuations

ARIES - Ambrisentan in Patients With Moderate to Severe Pulmonary Arterial Hypertension (PAH)

Find Trials by Condition in New York

Safety and Efficacy of Avonex in Subjects With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)

Study of BMS-587101 in Patients With Moderate to Severe Psoriasis

Study of Ipilimumab (MDX-010) Monotherapy in Patients With Previously Treated Unresectable Stage III or IV Melanoma

Diabetes Control and Complications Trial (DCCT)

Bryostatin 1 and Cytarabine in Treating Patients With Relapsed Acute Myelogenous Leukemia

Bone Marrow Transplantation in Treating Patients With Leukemia, Myelodysplasia, or Lymphoblastic Lymphoma

A Randomized, Placebo-Controlled Trial of BMS-275291 Given Daily for 12 Months to Women With Stage 1c-IIIA Breast Cancer Receiving Adjuvant Chemotherapy and/or Hormonal Therapy

Study of XL784 in Patients With Albuminuria Due to Diabetic Nephropathy

Urinary Kidney Injury Molecule-1 (KIM-1) Excretion As Biomarker for Injury in Kidney Transplant Recipients

Rasagiline in Advanced Parkinson's Disease Patients With Motor Fluctuations Treated With Levodopa/Carbidopa Therapy.

Preimplantation Genetic Diagnosis for the Indication of Advanced Reproductive Age

A Phase I Study of BMS-275183 (Oral Taxane) Given on a Daily Schedule in Combination With Esomeprazole (Nexium) in Patients With Advanced Cancer

Multiple Ascending Dose Study of BMS-582949 in Patients With Stable Rheumatoid Arthritis on the Methotrexate Background

A Study of the Safety and Efficacy of Tobramycin for Inhalation in Young Children With Cystic Fibrosis

Study of Lenalidomide and XRT in Patients With Newly Diagnosed Glioblastoma Multiforme

Safety of Intravitreal POT-4 Therapy for Patients With Neovascular Age-Related Macular Degeneration (AMD)

A Phase I Study of BMS-275183 Given on a Daily Schedule in Patients With Advanced Malignancies